We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.29T
AUM Growth
-$219M
(-0.01%)
Cap. Flow
+$31.2B
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
14.44%
Holding
4,163
New
99
Increased
2,949
Reduced
960
Closed
63
Avg Time Held
15.5
quarters
Top 10 Avg Time Held
11.2
quarters
Top 20 Avg Time Held
13.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$1.53B |
| 2 |
American Tower
AMT
|
+$1.49B |
| 3 |
McDonald's
MCD
|
+$1.13B |
| 4 |
Crown Castle
CCI
|
+$1.07B |
| 5 |
Alibaba
BABA
|
+$970M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$762M |
| 2 |
Amgen
AMGN
|
+$595M |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$497M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$468M |
| 5 |
POT
Potash Corp Of Saskatchewan
POT
|
+$427M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.91% |
| 2 | Financials | 16.33% |
| 3 | Healthcare | 12.63% |
| 4 | Industrials | 10.89% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
DELISTED
KalVista Pharmaceuticals
KALV
| $1.11M | ﹤0.01% |
117,095
-1,243
| -1% | -$13K |
2015 Q2
11 quarters
|
|
|
DEST
3627
DELISTED
Destination Maternity Corporation
DEST
| $1.1M | ﹤0.01% |
424,982
+98,382
| +30% | +$238K |
2013 Q2
19 quarters
|
|
3628
Lisata Therapeutics
LSTA
$11.5M
| $1.09M | ﹤0.01% |
12,497
+5,693
| +84% | +$394K |
2013 Q2
19 quarters
|
|
3629
Lipocine
LPCN
$14.2M
| $1.09M | ﹤0.01% |
42,038
+2,777
| +7% | +$77.3K |
2014 Q3
14 quarters
|
|
|
XPLR
3630
DELISTED
Xplore Technologies Corp.
XPLR
| $1.09M | ﹤0.01% |
336,824
+39,677
| +13% | +$122K |
2013 Q4
17 quarters
|
|
|
ALJJ
3631
DELISTED
ALJ Regional Holdings Inc
ALJJ
| $1.07M | ﹤0.01% |
511,348
+35,888
| +8% | +$99.2K |
2016 Q2
7 quarters
|
|
|
ESBK
3632
DELISTED
Elmira Savings Bank Elmira NY
ESBK
| $1.07M | ﹤0.01% |
55,460
+1,836
| +3% | +$35.9K |
2017 Q3
2 quarters
|
|
|
XIN
3633
DELISTED
Xinyuan Real Estate
XIN
| $1.07M | ﹤0.01% |
20,245
+2,028
| +11% | +$136K |
2013 Q3
18 quarters
|
|
3634
Tempest Therapeutics
TPST
$12.8M
| $1.07M | ﹤0.01% |
450
+5
| +1% | +$15K |
2013 Q2
19 quarters
|
|
3635
DELISTED
Astria Therapeutics
ATXS
| $1.06M | ﹤0.01% |
9,745
+465
| +5% | +$46.5K |
2015 Q2
11 quarters
|
|
|
BNBX
3636
DELISTED
BNB PLUS CORP
BNBX
| $1.05M | ﹤0.01% |
1
| – | – |
2015 Q1
12 quarters
|
|
3637
DELISTED
Evoke Pharma
EVOK
| $1.05M | ﹤0.01% |
3,513
-12
| -0.3% | -$3.95K |
2013 Q4
17 quarters
|
|
3638
DELISTED
The L.S. Starrett Company
SCX
| $1.04M | ﹤0.01% |
154,109
-1,990
| -1% | -$16.2K |
2013 Q2
19 quarters
|
|
|
OXFD
3639
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.03M | ﹤0.01% |
83,007
+3,415
| +4% | +$41.6K |
2014 Q1
16 quarters
|
|
3640
NanoViricides
NNVC
$33.2M
| $1.03M | ﹤0.01% |
62,675
+611
| +1% | +$11.3K |
2013 Q4
17 quarters
|
|
3641
Virco
VIRC
$102M
| $1.02M | ﹤0.01% |
248,840
+13,699
| +6% | +$61.8K |
2013 Q2
19 quarters
|
|
3642
DELISTED
Altisource Asset Management Corp
AAMC
| $1.02M | ﹤0.01% |
27,793
+850
| +3% | +$33.5K |
2013 Q4
17 quarters
|
|
3643
Friedman Industries
FRD
$303M
| $1.02M | ﹤0.01% |
173,279
+4,099
| +2% | +$23.9K |
2013 Q2
19 quarters
|
|
3644
PDS Biotechnology
PDSB
$100M
| $1.02M | ﹤0.01% |
43,027
+66
| +0.2% | +$17.8K |
2015 Q4
9 quarters
|
|
3645
DELISTED
Venus Concept
VERO
| $1.01M | ﹤0.01% |
66
+22
| +50% | +$293K |
2017 Q4
1 quarter
|
|
3646
Vanguard Materials ETF
VAW
$2.87B
| $1M | ﹤0.01% |
7,792
+120
| +2% | +$16.4K |
2016 Q4
5 quarters
|
|
3647
DELISTED
Christopher & Banks Corporation
CBK
| $1M | ﹤0.01% |
938,657
+24,911
| +3% | +$29K |
2013 Q2
19 quarters
|
|
3648
Red Violet
RDVT
$1.28B
| $1M | ﹤0.01% |
+164,256
| New | +$987K |
2018 Q1
0 quarters
|
|
3649
Espey Mfg & Electronics Corp
ESP
$172M
| $985K | ﹤0.01% |
37,579
-400
| -1% | -$10.1K |
2017 Q3
2 quarters
|
|
3650
Moleculin Biotech
MBRX
$9.01M
| $984K | ﹤0.01% |
243
+39
| +19% | +$169K |
2016 Q4
5 quarters
|
|
Similar funds
CWM
FAF
BGIM
CIM
UOC
Vanguard Group's Q1 2018 Portfolio in Review
As of Q1 2018, Vanguard Group held 4,163 positions worth $2.29T, down 0.01% from $2.29T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 3.9%. Vanguard Group opened 99 new positions and exited 63, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2018 buy was Nutrien: 16,386,239 shares worth $774M.
- Vanguard Group added most to Walmart Inc in Q1 2018, an estimated $1.53B increase.
- Vanguard Group's biggest Q1 2018 reduction was Amgen, cutting an estimated $595M.
- Vanguard Group fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $762M.
- Vanguard Group's ten largest holdings make up 14% of its $2.29T portfolio in Q1 2018.
- Vanguard Group opened 99 new positions and closed 63 in Q1 2018.
- Vanguard Group's portfolio value fell 0.01% quarter-over-quarter to $2.29T.
Based on Vanguard Group's 13F filing for Q1 2018, filed 15 May 2018.